𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effectiveness of cryosupernatant therapy in refractory and chronic relapsing thrombotic thrombocytopenic purpura

✍ Scribed by G. T. Obrador; Z. R. Zeigler; R. K. Shadduck; C. S. Rosenfeld; J. B. Hanrahan

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
332 KB
Volume
42
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

This report describes objective improvement in two patients with poorly responsive thrombotic thrombocytopenic purpura (TTP) syndromes (with cryosupernatant). The first had a partial response to plasma exchange with whole plasma (fresh frozen plasma; FFP) and responded dramatically when switched to plasma exchange with cryosupernatant replacement. The second had chronic TTP (three relapses in 9 months) that required prolonged courses of exchange with FFP (∼ 1 month each) to achieve remission. Attempts to manage her recurrent TTP with infusion of two units of FFP had been unsuccessful. The latter patient was tried on cryosupernatant infusions (2 units daily) and responded within 4 days. Moreover, she has been in continuous remission for 12 months while receiving 2 units (one to three times per week). These results suggest that cryoprecipitate‐poor plasma may offer advantages over whole plasma in the management of both acute and chronic forms of TTP. Β© 1993 Wiley‐Liss, Inc.

πŸ“œ SIMILAR VOLUMES

Cyclosporine therapy in refractory/relap
Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura
✍ Annamaria Nosari; Rosaria Redaelli; Teresa Maria Caimi; Gianni Mostarda; Enrica πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 289 KB πŸ‘ 2 views

To the editor: The interesting article by van Beers et al. states that functional studies does not offer clues as to the presence of mild pulmonary hypertension (PH) in patients with sickle cell disease (SCD) [1]. However, they did show that although not statistically significant, lung function find

Chronic relapsing thrombotic thrombocyto
Chronic relapsing thrombotic thrombocytopenic purpura: Role of therapy with cyclosporine
✍ Pasquale, Donald; Vidhya, Rakesh; DaSilva, Karen; Tsan, Min-Fu; Lansing, Lawrenc πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 31 KB πŸ‘ 2 views

Relapsing thrombotic thrombocytopenic purpura (TTP) is a rare disorder with most individuals experiencing 1 to 5 relapses. We report a patient with 18 episodes of thrombotic thrombocytopenic purpura (TTP), the highest number of relapses thus far described. The last 11 episodes were treated with regi

Rituximab for treatment of refractory/re
Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP)
✍ Afaq Ahmad; Anita Aggarwal; Daya Sharma; Harish P. Dave; Virginia Kinsella; Marg πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 1 views

## Abstract Plasma exchange is the standard treatment for thrombotic thrombocytopenic purpura (TTP). For patients refractory to plasma exchange, treatment options are limited and often unsuccessful. The platelet thrombi that form in acquired TTP are believed to result from the presence of procoagul

Chronic relapsing thrombotic thrombocyto
Chronic relapsing thrombotic thrombocytopenic purpura and antiphospholipid antibodies: A report of two cases
✍ Trent, Kelley; Neustater, Brett R.; Lottenberg, Richard πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

We report on 2 cases of chronic relapsing thrombotic thrombocytopenic purpura, in which anti-phospholipid antibodies were also found. The first patient was felt to have the antiphospholipid antibody syndrome, while the second patient had anti-phospholipid antibodies without clinical manifestations o